End of the EUA Era: FDA begins to wind down emergency authorizations for COVID-19 tests

End of the EUA Era: FDA begins to wind down emergency authorizations for COVID-19 tests

By Conor Hale

After more than 430 emergency green lights for COVID-19 tests since the start of the pandemic, the FDA is beginning to wind down its expedited review programs for coronavirus diagnostics, instead urging developers to follow its traditional regulatory paths to market.